Atrial fibrillation: Difference between revisions
No edit summary |
No edit summary |
||
(139 intermediate revisions by 29 users not shown) | |||
Line 1: | Line 1: | ||
{| | __NOTOC__ | ||
| | |||
{| class="infobox" style="float:right;" | |||
|- | |||
|[[File:Siren.gif|30px|link=Atrial fibrillation resident survival guide]]||<br>||<br> | |||
|[[Atrial fibrillation resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{| class="infobox" style="float:right;" | |||
|- | |||
|[[Image:Heart conduct sinus.gif|150px|]]<BR><small>'''Sinus rhythm'''</small> | |||
|} | |||
{| class="infobox" style="float:right;" | |||
|- | |- | ||
| | |[[Image:Heart conduct atrialfib.gif|150px]]<BR><small>'''Atrial fibrillation'''</small> | ||
|} | |} | ||
{{ | {{Atrial fibrillation}} | ||
{{Patient}} | |||
{{CMG}} {{AE}} {{Anahita}} {{Laith}} {{SemRikken}} | |||
{{SK}} AF; afib; lone fibrillator | |||
==[[Atrial fibrillation overview|Overview]]== | |||
==[[Atrial fibrillation historical perspective|Historical Perspective]]== | |||
==[[Atrial fibrillation classification|Classification]]== | |||
==[[Atrial fibrillation pathophysiology|Pathophysiology]]== | |||
}} | ==[[Atrial fibrillation causes|Causes]]== | ||
{{ | |||
{{ | |||
{{ | |||
==[[Atrial fibrillation differential diagnosis|Differentiating Atrial Fibrillation from other Diseases]]== | |||
==[[Atrial fibrillation epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Atrial fibrillation risk factors|Risk Factors]]== | |||
== | ==[[Atrial fibrillation screening|Screening]]== | ||
===[[Atrial fibrillation | ==[[Atrial fibrillation natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
==Special Groups== | |||
[[Postoperative atrial fibrillation|Postoperative AF]] | [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]] | [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Preexcitation Syndromes]] | [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]] | [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | [[Atrial fibrillation pregnancy|Pregnancy]] | [[Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention|Patients Presenting with ACS and/or PCI or Valve Intervention]] | |||
==Diagnosis== | ==Diagnosis== | ||
[[Atrial fibrillation history and symptoms|History and Symptoms]] | [[Atrial fibrillation physical examination|Physical Examination]] | [[Atrial fibrillation laboratory findings|Laboratory Findings]] | [[Atrial fibrillation electrocardiogram|Electrocardiogram]] | [[Atrial fibrillation EKG examples|EKG Examples]] | [[Atrial fibrillation with LBBB EKG examples|Afib with LBBB EKG Examples]] | [[Atrial fibrillation chest x ray|Chest X Ray]] | [[Atrial fibrillation echocardiography or ultrasound|Echocardiography]] | [[Atrial fibrillation other imaging findings|Holter Monitoring and Exercise Stress Testing]] | [[Atrial fibrillation cardiac MRI|Cardiac MRI]] | |||
==[[Atrial fibrillation overview of treatment|Treatment]]== | |||
===[[Atrial fibrillation rate control|Rate and Rhythm Control]]=== | |||
[[Atrial fibrillation rate control|Rate Control]] | [[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]] | |||
===[[Atrial fibrillation | |||
== | ===Cardioversion=== | ||
===[[Atrial fibrillation | [[Atrial fibrillation cardioversion|Overview]] | [[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]] | [[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]] | ||
== | ===Anticoagulation=== | ||
===[[Atrial fibrillation | [[Atrial fibrillation anticoagulation|Overview]] | [[Warfarin]] | [[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]] | [[Dabigatran]] | ||
==[[ | ===Dabigatran=== | ||
[[dabigatran#Dosing|Dosing]] | [[Dabigatran#Surgery and Interventions|Discontinuation for Surgery and Interventions]] | [[Dabigatran#WARNINGS AND PRECAUTIONS| Warnings and Precautions]] | [[Dabigatran#Adverse Reactions|Adverse Reactions]] | [[Dabigatran#Use in Specific Populations|Use in Specific Populations Such as Pregnancy]] | [[Dabigatran#Overdosage|Overdosage]] | [[Clinical Pharmacology of Dabigatran|Clinical Pharmacology]] | [[FDA Review of Data From the RE-LY Trial on September 20th, 2010|FDA Review of the RE-LY Data]] | [[A comparison of the RE-LY and Rocket AF Trials ]] | [[Estimates of Cost Per Year of Life Saved for Dabigatran]] | |||
== | ===Ablation=== | ||
[[Atrial fibrillation catheter ablation|Catheter Ablation]] | [[AV nodal ablation|AV Nodal Ablation]] | [[Atrial fibrillation surgical ablation|Surgical Ablation]] | |||
===Surgery=== | |||
[[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]] | |||
== | ===[[Atrial fibrillation secondary prevention|Secondary Prevention]]=== | ||
== | ===[[Atrial fibrillation supportive trial data|Supportive Trial Data]]=== | ||
===[[Atrial fibrillation cost-effectiveness of therapy|Cost-effectiveness of Therapy]]=== | |||
== | ==Case Studies== | ||
[[Atrial fibrillation case study one|Case #1]] | |||
* | |||
==Related Chapters== | |||
*[[Atrial flutter]] | |||
*[[Ashman phenomenon]] | |||
*[[The Living Guidelines: Diagnosis and Management of Atrial Fibrillation | The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]] | |||
{{Electrocardiography}} | {{Electrocardiography}} | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Arrhythmia]] | |||
[[Category:Cardiology]] | |||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date Cardiology]] | |||
[[ | |||
[[ | |||
Latest revision as of 20:15, 21 October 2024
Resident Survival Guide |
Sinus rhythm |
Atrial fibrillation |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation On the Web | |
For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Laith Adnan Allaham, M.D.[3] Sem A.O.F. Rikken, M.D.[4]
Synonyms and keywords: AF; afib; lone fibrillator
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hypertrophic Cardiomyopathy | Hyperthyroidism | Pulmonary Diseases | Pregnancy | Patients Presenting with ACS and/or PCI or Valve Intervention
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Afib with LBBB EKG Examples | Chest X Ray | Echocardiography | Holter Monitoring and Exercise Stress Testing | Cardiac MRI
Treatment
Rate and Rhythm Control
Rate Control | Maintenance of Sinus Rhythm
Cardioversion
Overview | Electrical Cardioversion | Pharmacological Cardioversion
Anticoagulation
Overview | Warfarin | Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants | Dabigatran
Dabigatran
Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Ablation
Catheter Ablation | AV Nodal Ablation | Surgical Ablation